found that by inhibiting both cellular constituents in this exchange, a combination strategy targeting glutamine synthetase in fibroblasts alongside glutaminase in cancer cells reduced tumor weight and metastatic burden in orthotopic mouse ovarian cancer models (23). This evidence concerns the gene GLS and cancer.